Previous 10 | Next 10 |
HOUSTON and VANCOUVER , June 26, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer provides an update, further to the announcement made on May 16...
Updates: I did not expect that Essa Pharma ( EPIX )/Realm Therapeutics ( RLM ) transaction (previous write up here ) will actually get approved, but unfortunately it happened . Effective date is set on the 2nd of July. As I said earlier, this deal is a complete rip off of the shareholder...
HOUSTON, TX AND VANCOUVER , June 25, 2019 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the votes on ...
ESSA Pharma to Hold Annual Shareholders' Meeting and Announces Three Realm-Nominated Directors Canada NewsWire HOUSTON, TX and VANCOUVER, June 21, 2019 HOUSTON, TX and VANCOUVER , June 21, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX; TSX-V: EPI...
Realm Therapeutics ( RLM ) - Essa Pharma ( EPIX ) Spread: 11% Realm is a failed biopharma company that trades at a considerable discount (0.47x) to its NAV (initial article here ). It have recently sold all of their assets and now remains as a cash shell with a listing on Nasdaq. So, ...
Introduction On the 16th of May, Realm Therapeutics ( RLM ) announced it had reached agreement to be acquired in an all-stock-deal by ESSA Pharma ( EPIX )/(TSEV: EPI). In this article, I'll explain why, as a Realm shareholder, I believe this transaction is an extremely bad deal, and wh...
ESSA Pharma (NASDAQ: EPIX ) has entered into a definitive agreement to acquire Realm Therapeutics (NASDAQ: RLM ) in an all-stock transaction. More news on: ESSA Pharma Inc., Realm Therapeutics Plc, Healthcare stocks news, Read more ...
Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics Canada NewsWire VANCOUVER and HOUSTON, May 16, 2019 Acquisition Expected to be Completed by Mid-Year 2019 VANCOUVER and HOUSTON , May 16, 2019 /CNW/ - ESSA Pharma Inc. (" ESSA " or "the Compan...
ESSA Pharma (NASDAQ: EPIX ): Q2 GAAP EPS of -$0.54 misses by $0.10 . More news on: ESSA Pharma Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019 Canada NewsWire HOUSTON, TX and VANCOUVER, May 10, 2019 HOUSTON , TX and VANCOUVER , May 10, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI, NASDAQ: EPIX), ...
News, Short Squeeze, Breakout and More Instantly...
ESSA Pharma to Present at the JonesHealthcare Seaside Summit Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , July 8, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on de...
ESSA Pharma to Present at the Jefferies Global Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , May 30, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focus...